Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-01-21 @ 3:43 PM
Study NCT ID:
NCT00623766
Status:
COMPLETED
Last Update Posted:
2014-06-09
First Post:
2008-02-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA184-042
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |